Key result
Stem cell-based therapy for myocardial repair requires optimization of donor cells and target cardiac microenvironments to enhance engraftment and clinical efficacy.
This review outlines current strategies and challenges in optimizing stem cell-based therapies for myocardial repair in ischemic heart disease.
No takes yet. Share an insight, caveat, or question.
Stem cell therapy for myocardial repair should not yet enter routine practice; leaves open optimal donor cell and microenvironment combinations in future trials.
Wu et al. (2018) conducted a review in Ischemic heart diseases. Stem cell-based therapy was evaluated. Stem cell-based therapy for myocardial repair requires optimization of donor cells and target cardiac microenvironments to enhance engraftment and clinical efficacy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: